Search

Search bills, members, committees and pages...

Sign In

ASTRAZENECA PHARMACEUTICALS LP

PreviousNext

14 federal lobbying filings, 2023 to 2026.

ASTRAZENECA PHARMACEUTICALS LP is a registrant on 14 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Clients

1 who it filed for, by filings.

ClientFilingsReported
ASTRAZENECA PHARMACEUTICALS LP14—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$4M
20254—$5.1M
20244—$2.9M
20234—$3.9M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
CPTCopyright/Patent/Trademark14
HCRHealth Issues14
MMMMedicare/Medicaid14
PHAPharmacy14
TAXTaxation/Internal Revenue Code14
TARTariff (miscellaneous tariff bills)5
INSInsurance3
TRDTrade (domestic/foreign)3
BUDBudget/Appropriations2
LBRLabor Issues/Antitrust/Workplace1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1414Cameron’s Law6
H.R. 591Defending American Jobs and Investment Act6
H.R. 946ORPHAN Cures Act6
H.R. 1262Mikaela Naylon Give Kids a Chance Act5
H.R. 1990American Innovation and R&D Competitiveness Act of 20255
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.3
H.R. 2423Unfair Tax Prevention Act3
H.R. 4132Prescription Information Modernization Act of 20253
S. 998Medical Supply Chain Resiliency Act3
H.R. 6166Lowering Drug Costs for American Families Act2
S. 1605International Competition for American Jobs Act2
H.R. 1503Stop Forced Organ Harvesting Act of 20251
H.R. 1911To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subjec…1
H.R. 3521Clinical Trial Modernization Act1
H.R. 4695Facial Recognition Act of 20251
H.R. 5509Safe Step Act1
H.R. 7118Genomic Answers for Children’s Health Act of 20261
H.R. 9599SECURE 340B Act1
S. 1639American Innovation and Jobs Act1
S. 3841Last Sale Valuation Act of 20261

Lobbyists

Named on the filings.

LobbyistClientsFilings
KATIE JONES114
SARAH ARBES114
CAROLINE QUAT113
ART MOTTA19
LISA LANGENDERFER18
EMILY MACE15
ELIZABETH BROOKS14
HELEN DWIGHT13
AARON HUNTER12
BAILEY MCCUE11
TALEEN MEKHDJAVAKIAN11
THADDEUS FLOOD11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2026 second_quarter$1.7MJul 20, 2026
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2026 first_quarter$2.3MApr 20, 2026
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2025 fourth_quarter$670KJan 20, 2026
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2025 third_quarter$1.4MOct 17, 2025
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2025 second_quarter$1.8MJul 21, 2025
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2025 first_quarter$1.2MApr 21, 2025
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2024 fourth_quarter$640KJan 21, 2025
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2024 third_quarter$650KOct 21, 2024
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2024 second_quarter$950KJul 22, 2024
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2024 first_quarter$700KApr 22, 2024
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2023 fourth_quarter$830KJan 22, 2024
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2023 third_quarter$950KOct 20, 2023
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2023 second_quarter$830KJul 20, 2023
ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP2023 first_quarter$1.3MApr 20, 2023